Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 4Prostatic Neoplasms 3Oropharyngeal Neoplasms 2Endometrial Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Neurocognitive Disorders 1Meningioma 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoglobulin G4-Related Disease 1Carcinoma, Renal Cell 1Carcinoma, Adenoid Cystic 1Carcinoma 1Breast Carcinoma In Situ 1Autoimmune Pancreatitis 1Anus Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1Anal Canal Carcinoma 1

Interventions

Cisplatin 13Magnetic Resonance Spectroscopy 9Specimen Handling 8Radiotherapy 7Platinum 71,2-diaminocyclohexaneplatinum II citrate 7Radiotherapy, Intensity-Modulated 4Radiation 4Biopsy 4Surveys and Questionnaires 3Nivolumab 3Carboplatin 3pembrolizumab 2durvalumab 2Observation 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Docetaxel 2Disulfides 2Chemoradiotherapy 2Cetuximab 2(225)Ac-DOTA-c(RGDyK) 2niraparib 1merphos 1ipatasertib 1dostarlimab 1cemiplimab 1cabozantinib 1balstilimab 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Observation × 30 days × Clear all
NCT03811015 2026-05-29

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
636 enrolled
Head & Neck

Oropharyngeal Neoplasms

NCT05541016 2026-05-12

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Mayo Clinic

Phase 2 Recruiting
455 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡